<DOC>
	<DOCNO>NCT01727713</DOCNO>
	<brief_summary>The goal current trial determine safety Once-daily aripiprazole reduce Total Tic Severity child adolescents Tourette 's Disorder .</brief_summary>
	<brief_title>Safety Tolerability Once-daily Oral Aripiprazole Children Adolescents With Tourette 's Disorder</brief_title>
	<detailed_description>Tourette 's Disorder neuropsychiatric condition characterize appearance tic simple complex nature . A tic sudden , rapid , recurrent , non-rhythmic , stereotype motor movement vocalization . There limited number medication approve treatment Tourette 's Disorder . The goal current trial obtain additional efficacy , safety , tolerability data control condition Once-daily aripiprazole formulation child adolescents Tourette 's Disorder . The trial 52-week extension double-blind trial . The Once-daily tablet formulation evaluate trial represent daily dosage regimen intend administered child adolescent .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Tic Disorders</mesh_term>
	<mesh_term>Tics</mesh_term>
	<mesh_term>Tourette Syndrome</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Completed participation Trial 3112293 Written ICF obtain legally acceptable representative &amp; informed assent Baseline applicable trial center 's IRB/IEC The subject , designate guardian ( ) caregiver ( ) able comprehend satisfactorily comply protocol requirement , evaluate investigator Experienced AEs doubleblind trial ( 3112293 ) would , investigator 's judgment , preclude exposure aripiprazole . The subject protocol violation doubleblind trial consider major judgment investigator would deem subject poor candidate trial A positive drug screen Sexually active patient use 2 approved method contraception Females breastfeeding pregnant ( positive blood pregnancy test prior receive trial drug ) Risk commit suicide Body weight low 16 kg Abnormal laboratory test result , vital sign ECG result</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Tourette Syndrome</keyword>
	<keyword>Basal Ganglia Diseases</keyword>
	<keyword>Brain Diseases</keyword>
	<keyword>Central Nervous System Diseases</keyword>
	<keyword>Tic Disorders</keyword>
	<keyword>Tics</keyword>
	<keyword>Movement Disorders</keyword>
	<keyword>Mental Disorders</keyword>
	<keyword>Aripiprazole</keyword>
</DOC>